---
layout: default
---

# Configurations

| UniProt Accession Number   | Reagent Type     | Target Name / Protein Biomarker   | Target Species   | Host Organism   | Isotype   | Clonality   | Vendor    |   Catalog Number | Conjugate   | RRID       | Availability   | Method        | Tissue Preservation   | Target Tissue   | Tissue State    | Detergent         | Antigen Retrieval Conditions                                  | Dye Inactivation Conditions   | Recommend   | Agree               | Disagree   | Contributor         | Notes       |
|:---------------------------|:-----------------|:----------------------------------|:-----------------|:----------------|:----------|:------------|:----------|-----------------:|:------------|:-----------|:---------------|:--------------|:----------------------|:----------------|:----------------|:------------------|:--------------------------------------------------------------|:------------------------------|:------------|:--------------------|:-----------|:--------------------|:------------|
| P01732                     | Primary Antibody | CD8                               | Human            | Mouse           | IgG1      | C8/144B     | BioLegend |           372906 | AF647       | AB_2650712 | Stock          | IBEX2D Manual | FFPE                  | Heart           | NA              | 0.3% Triton-X-100 | pH 6 for 40 minutes at 95C (AR6 Akoya Biosciences AR600250ML) | 1 mg/ml LiBH4 15 minutes      | Yes         | [0000-0002-7586-9996](https://orcid.org/0000-0002-7586-9996) | NA         | [0000-0002-7586-9996](https://orcid.org/0000-0002-7586-9996) | [1](#notes) |
| P01732                     | Primary Antibody | CD8                               | Human            | Mouse           | IgG1      | C8/144B     | BioLegend |           372906 | AF647       | AB_2650712 | Stock          | IBEX2D Manual | FFPE                  | Skin            | Infected        | 0.3% Triton-X-100 | pH 6 for 40 minutes at 95C (AR6 Akoya Biosciences AR600250ML) | 1 mg/ml LiBH4 15 minutes      | Yes         | [0000-0002-7586-9996](https://orcid.org/0000-0002-7586-9996) | NA         | [0000-0002-7586-9996](https://orcid.org/0000-0002-7586-9996) | [2](#notes) |
| P01732                     | Primary Antibody | CD8                               | Human            | Mouse           | IgG1      | C8/144B     | BioLegend |           372906 | AF647       | AB_2650712 | Stock          | IBEX2D Manual | FFPE                  | Cervix          | Cervical Cancer | 0.3% Triton-X-100 | pH 6 for 40 minutes at 95C (AR6 Akoya Biosciences AR600250ML) | 1 mg/ml LiBH4 15 minutes      | Yes         | [0000-0002-7586-9996](https://orcid.org/0000-0002-7586-9996) | NA         | [0000-0002-7586-9996](https://orcid.org/0000-0002-7586-9996) | [3](#notes) |

# Publications



# Additional Notes

<a name="notes"></a>
1. Evaluated in human FFPE tissues with CD45 and Hoechst (nuclear marker). Antibody yields anticipated staining pattern. Performed using manual IBEX protocol with antibody incubation using the Pelco Biowave microwave.
2. Evaluated in human FFPE tissues from cutaneous leishmania lesion with CD3 and Hoechst (nuclear marker). Antibody yields anticipated staining pattern. Performed using manual IBEX protocol with antibody incubation using the Pelco Biowave microwave.
3. Evaluated in human FFPE tissues with CD3 and Hoechst (nuclear marker). Antibody yields anticipated staining pattern. Performed using manual IBEX protocol with antibody incubation using the Pelco Biowave microwave.
